Absolutely agree. What are some of your other favorites? I like GILD and CELG.
I'm in for 20k.
Manipulation. Options expiration Friday. Tiny float. Insiders making money on swing trades. Play along if you'd like. They will be taking it down to $50 or so.
SAGE-547 works, no other drug exists for SRSE. FDA allowing it for emergency use (in addition to trials) tells you all you need to know. Will get approved, company could get bought before then. In the mean time average down, and tuck the shares away.
Right on schedule with these ALS results. That suggests we'll close green and break $4.
Look it up. Been the plan all along. Build a great product (check), get approval (check), secure adoption (in process), sell the company for a nice profit. We're on track. Acquisition price is somewhere north of $40.
I bought more shares. Seems cheap.
Is $32 your target as well, or do you think they'll push it below $30? A safe range would be around $26 or so.
Hoping news comes this week. It's been a couple since this was mentioned at the congressional hearing. A multi-million dollar deal with HHS would send this stock into the $70's.
Why would Roche care about a Phase 1 product? Something else in the works here. Roche has other motives at play. I think this goes back to the comments made at the congressional hearing about another large pharmaceutical that will be helping NewLink manufacturer Ebola vaccine.
I believe GSK said this weekend they are bowing out. I saw an earlier post about that, I'm looking for the article now. If someone has a link please post it.
Video is available on CSPAN for other investors to review.
Absolutely not. My point was to only illustrate how absurdly low the current valuation at $20 is.
At the congressional hearing last week, it the HHS doctor let it slip that NewLink was working with "A Large American Company" (see CSPAN video). A big pharmaceutical like JnJ or Pfizer could easily ramp and help produce that many does. I'd expect an announcement this week.